Aptevo Therapeutics (APVO) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-21.09
-14.62
-8.14
-1.67

Details

Expected EPS
-21.09
Actual EPS
-17.76
Surprise EPS
3.33
Surprise Percent
+15.79%

Description

Aptevo Therapeutics (APVO) has reported earnings of -17.76 per share for Q4 2024.

0 Comments

Share your thoughts